Litigation Details for UCB, Inc. v. Mylan Technologies, Inc. (D. Vt. 2019)
✉ Email this page to a colleague
UCB, Inc. v. Mylan Technologies, Inc. (D. Vt. 2019)
| Docket | ⤷ Subscribe | Date Filed | 2019-07-16 |
| Court | District Court, D. Vermont | Date Terminated | 2021-06-08 |
| Cause | 35:271 Patent Infringement | Assigned To | |
| Jury Demand | None | Referred To | |
| Patents | 10,130,589; 10,350,174; 9,925,150 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in UCB, Inc. v. Mylan Technologies, Inc.
The small molecule drug covered by the patents cited in this case is ⤷ Subscribe .
Details for UCB, Inc. v. Mylan Technologies, Inc. (D. Vt. 2019)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2020-07-15 | 101 | Discovery Certificate | Craig Dyar, Ph.D. on Invalidity of U.S. Patent Nos. 10,130,589 AND 10,350,174, Repbuttal Expert Report… 2019 8 June 2021 2:19-cv-00128 830 Patent None District Court, D. Vermont | External link to document |
| 2021-07-09 | 142 | Declaration of Jim Trainor | Delaware concerning U.S. Patent No. 10,130,589 (“’589 Patent”), one of the same patents at-issue in this litigation…prejudice with respect to the '174 patent. That's the patent 9 that was not at issue before…with respect to that patent. 12 And then with respect to the '589 patent, your Honor, the 13… that left open the 12 possibility that these patents were valid, that they would 13 reassert those …Jordan but is closely 10 related to the '589 patent, and there would be a stipulation of 11 dismissal | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
